Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
(NCI)-designated Purdue Institute for Cancer Research Purdue Institute for Integrative Neuroscience (PIIN) Purdue Institute of Inflammation, Immunology and Infectious Disease (PI4D) Regenstrief Center
-
Assistant/Associate Professor - AI-Driven Biomolecular Design, Biotechnology, and Computational Biol
Institute for Cancer Research Bindley Bioscience Center Purdue has existing research capabilities in biomolecular sciences, AI, computational biology, and structural biology, with key strengths in: Structural
-
-institutional prostate cancer research studies. This position will work as part of a multi-disciplinary team that includes clinicians, statisticians, epidemiologists, and bench scientists. Complexities
-
datasets, and collaborating with cross-functional teams between the Breast Cancer Now Unit at King’s College London and the Breast Cancer Now Centre at The Institute for Cancer Research to drive discoveries
-
datasets, and collaborating with cross-functional teams between the Breast Cancer Now Unit at King’s College London and the Breast Cancer Now Centre at The Institute for Cancer Research to drive discoveries
-
Breast Cancer Now Centre at The Institute for Cancer Research to drive discoveries in immune-oncology of pre- and post-neoadjuvant treated triple negative breast cancer biology. This is a full time and you
-
are working together to translate research discoveries into developing kinder, more effective therapies for cancer patients. The Cancer Institute includes the Cancer Research UK and UCL Cancer Trials Centre
-
into the role of Director of the Cancer Research UK Manchester Institute. As Executive Assistant to the Director, you’ll be at the heart of a world-leading scientific institution—helping shape its next chapter
-
such as the Ontario Institute for Cancer Research and Public Health Ontario , with whom our researchers partner, are also based in Toronto. Toronto is a vibrant, safe, multicultural city with excellent
-
work on the INSTINCT-MB programme, which brings together teams based at Newcastle University, The Institute of Cancer Research and University College London. The programme will generate a wide range of